"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
| Descriptor ID |
D014157
|
| MeSH Number(s) |
D12.776.930
|
| Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 14 | 10 | 24 |
| 1997 | 28 | 14 | 42 |
| 1998 | 24 | 8 | 32 |
| 1999 | 35 | 11 | 46 |
| 2000 | 38 | 14 | 52 |
| 2001 | 45 | 12 | 57 |
| 2002 | 44 | 27 | 71 |
| 2003 | 48 | 32 | 80 |
| 2004 | 58 | 23 | 81 |
| 2005 | 46 | 36 | 82 |
| 2006 | 30 | 21 | 51 |
| 2007 | 31 | 23 | 54 |
| 2008 | 29 | 16 | 45 |
| 2009 | 27 | 21 | 48 |
| 2010 | 30 | 18 | 48 |
| 2011 | 24 | 19 | 43 |
| 2012 | 27 | 26 | 53 |
| 2013 | 30 | 32 | 62 |
| 2014 | 25 | 38 | 63 |
| 2015 | 35 | 25 | 60 |
| 2016 | 29 | 28 | 57 |
| 2017 | 30 | 31 | 61 |
| 2018 | 28 | 18 | 46 |
| 2019 | 20 | 28 | 48 |
| 2020 | 31 | 30 | 61 |
| 2021 | 25 | 20 | 45 |
| 2022 | 8 | 28 | 36 |
| 2023 | 17 | 33 | 50 |
| 2024 | 15 | 16 | 31 |
| 2025 | 16 | 11 | 27 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
Frequent synaptophysin expression in SMARCA4-deficient undifferentiated carcinoma of the oesophagus: a diagnostic pitfall with therapeutic implications. J Clin Pathol. 2026 Mar 19; 79(4):229-237.
-
Characterizing the interactions between murine cytomegalovirus M72 and the carbon catabolite repression 4-negative on TATA-less (CCR4-NOT) complex. Virology. 2026 Mar; 616:110791.
-
KRAS-ERK signaling drives metastasis in colorectal cancer via phosphorylation-dependent activation of the ZBTB20-TGFBR2 axis. J Exp Clin Cancer Res. 2026 Jan 02; 45(1):29.
-
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML. Leukemia. 2026 Feb; 40(2):304-313.
-
Single-nucleus multiomics reveals the disrupted regulatory programs in three brain regions of sporadic early-onset Alzheimer's disease. Sci Adv. 2025 Dec 19; 11(51):eadw4917.
-
Bromodomain-Driven Regulation of Stem Cells: A Potential Target for Cancer Therapeutic Intervention. Stem Cell Rev Rep. 2026 Feb; 22(2):767-802.
-
Cytohistologic Diagnosis of Rosette-Forming Epithelioid Osteosarcoma. Diagn Cytopathol. 2026 Mar; 54(3):E63-E66.
-
Transcriptional coregulator ZMIZ1 modulates estrogen responses that are essential for healthy endometrial function. J Clin Invest. 2025 Dec 01; 135(23).
-
Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases. Mod Pathol. 2025 Dec; 38(12):100906.
-
DNA methylation episignature for Smith-Magenis and Potocki-Lupski syndromes: a mirror perspective. Eur J Hum Genet. 2026 Jan; 34(1):90-98.